Pegfilgrastim biosimilar (Beijing SL Pharmaceutical) | Interleukin Related interleukin-related.com

Product Name :
Pegfilgrastim biosimilar (Beijing SL Pharmaceutical)

Search keywords :
G-CSF Receptor

drugId :
null

Target Vo:
Colony stimulating factor 3 receptor

Target Vo Short Name :
CSF3R

Moa_Name:
Haematopoiesis stimulants

First Approval Country :
Mainland China

First Approval Date Filter:
2023

Origin Company_Name :
Beijing Sl Pharmaceutical Co Ltd

Active Company_Name :
Beijing Sl Pharmaceutical Co Ltd

Active Indication_Name:
Neutropenia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FCGR1A Antibody
GFAP Antibody (YA755)
C3 Antibody: C3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 187 kDa, targeting to C3. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts